fr   en

Browse by date
Or search by keyword
Date: 2010-09-08
Company: Arcarios (Belgium) Tigenix (Belgium)
Investors: BioGeneration Ventures. Erasmus MC Biomedical Fund (The Netherlands) Gemma Frisius Fund (Belgium) CD3 (Belgium) Baekeland Fund II (Belgium) LRM (Belgium) Credit Agricole (France) VINNOF (Belgium)
Amount: €4.1 million
Planned use: Tigenix has announced the first closing of the seed-financing round for Arcarios. This spinout has been recently established jointyly with Therosteon (See agreements).